T.Rx Capital is a venture capital firm backing healthcare, biotechnology and health technology companies at the intersection of technology and biology. It invests across early and later-stage VC opportunities in the United States, with portfolio exposure to digital health, medical devices, radiopharmaceuticals and non-opioid pain innovation. The firm has acted as a lead or co-lead investor in healthcare financings.